Clinical Trial Update: Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating KD026 in combination with metformin for type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• KD026
• metformin (metformin)

Snippet

Sponsor: Response Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED